Large gap with delayed quotes
Last quote
12/27/2024 -
16:30:00
|
Bid
12/27/2024 -
15:59:59
|
Bid Volume |
Ask
12/27/2024 -
15:59:59
|
Ask Volume |
---|---|---|---|---|
341.12
-1.80
(
-0.52% )
|
341.07
|
300 |
341.71
|
100 |
Analysis date: 24.12.2024
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 13.12.2024.
Interest
Strong
Strong
Strong interest since 17.12.2024.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 13.12.2024 at a price of 345.93.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 06.12.2024), the stock traded above its moving average. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 334.541.
4wk Rel Perf
0.56%
0.56%
The four week relative performance versus SP500 is .
Sensibility
Middle
Middle
Moderate, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.48%.
Mkt Cap in $bn
10.54
10.54
With a market capitalization >$8bn, MEDPACE HOLDINGS is considered a large-cap stock.
G/PE Ratio
0.67
0.67
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
24.42
24.42
The estimated PE is for the year 2026.
LT Growth
16.44%
16.44%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
7
7
Over the last seven weeks, an average of 7 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
147
147
For 1% of index variation, the stock varies on average by 1.47%.
Correlation
0.42
0.42
42.28% of stock movements are explained by index variations.
Value at Risk
73.12
73.12
The value at risk is estimated at USD 73.12. The risk is therefore 21.34%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.11.2020
27.11.2020